Page 247 - An Evidence Review of Active Surveillance in Men With Localized Prostate Cancer

Appendix Table C1.3. Trends in mortality rates (per 100,000 person-yr unless otherwise stated) or survival (continued)
Author Database Groups 1980-84 1985-89 1990-94 1995-99 2000-04 2005-10 Statistical Notes
Year (yr) analysis
PMID
84
Kohler SEER, White -3.8 (P<0.05)
2011 NPCR, Black (1998) (2007) -4.2 (P<0.05)
21454908 NAACCR, Asian/Pacific -3.1 (P<0.05)
NCHS Islander
American -1.6 (P=NS)
Indian/ Alaska
Native -3.8 (P<0.05)
Hispanic -3.8 (P<0.05)
Non-hispanic [Average
Age-adjusted annual
(2000 US percentage
standard) change,
mortality rates 1998-2007]
51
Demers SEER- White 23.1 25.4 21.7 P<0.001 Additional
2001 Detroit Black 44.0 49.5 44.0 (decreasing information
11745285 Age-adjusted (1988) (1992) (1997) trend in is
(1970 US mortality presented
standard) rates, 1993- in Figure 1
mortality rates 98) of the
paper.
86
Barnholtz-Sloan SEER- Caucasian 0.33 0.36 (0.32, NR Only
2003 Detroit African (0.30, 0.39) patients
14575366 American 0.36) 0.36 (0.31, with distant
5-year relative 0.31 0.41) prostate
survival rates (0.28, (1990-1997) cancer
0.35)
(1980-
1989)
60
Godley SEER- Non-Hispanic 8.4 (8.3 to Not reached Not NR
2003 Medicare White 8.7) 7.8 (7.3 to reached
14625261 Black 6.8 (6.3 to 8.3) Not
Median 7.2) (1989-91) reached
survival time (1986-88) (1992-
following 96)
diagnosis, yr

C-41